Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs FitFlow

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and FitFlow head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 237 · Grade C

FitFlow

Visit FitFlow Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 66 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make FitFlow a bad call — it's best for readers comparing monthly and annual payment options who will confirm shipment cadence and the pharmacy-submission cutoff. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
46
Supply Reliability
95
75
Transparency
90
72
Access Breadth
93
56
Clinical Oversight
92
86
Track Record
88
68
CoreAge RxBrief Score 94 · 66FitFlow

Price, coverage & the tracker

CoreAge RxFitFlow
Brief Score94/100 (A)66/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

$175 billed monthly

Annual alternative: $1,188 upfront ($99/month equivalent); financing has separate terms.

Three months $435; six months $720. Confirm shipment cadence; no unused-period prorated refund.

Full price details

Compounded semaglutide $175 billed monthly; three months $435 upfront, six months $720 upfront, or annual $1,188 upfront ($99/month equivalent)

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

$235 billed monthly

Annual alternative: $1,608 upfront ($134/month equivalent); financing has separate terms.

Three months $597; six months $1,050. Confirm shipment cadence; no unused-period prorated refund.

Full price details

Compounded tirzepatide $235 billed monthly; three months $597 upfront, six months $1,050 upfront, or annual $1,608 upfront ($134/month equivalent)

CoverageUS only; restrictions by state, confirmed at intakeAdvertises clinician access in all fifty states; specific treatment availability may vary by state and clinical eligibility
Brand-name accessNot confirmedCurrent named GLP-1 products are compounded; brand-name fulfillment was not established.
Oral / sublingualInjection onlyUnconfirmed
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

FitFlow: Monthly billing is $175 semaglutide/$235 tirzepatide. The $99/$134 equivalents require $1,188/$1,608 annual commitments; financing is a separate arrangement.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.